Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 555-560

  Davare, Monika A ^a   Lal, Sangeet ^a   Peckham, Jennifer L ^a   Prajapati, Suresh I ^b   Gultekin, Sakir H ^c   Rubin, Brian P ^d   Keller, Charles ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Leptomeningeal metastasis; Medulloblastoma; VEGFA

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN A;

ARTICLE; CANCER CELL LINE; CELL MIGRATION; CONDITIONED MEDIA; CULTURE MEDIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDULLOBLASTOMA; PRIORITY JOURNAL;

LEPTOMENINGEAL METASTASIS; MEDULLOBLASTOMA; VEGFA;

CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES; HUMANS; MEDULLOBLASTOMA; MENINGES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904763450     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.06.018     Document Type: Article

References (24)

1. M.C. Fruhwald, and C. Plass Metastatic medulloblastoma-therapeutic success through molecular target identification? Pharmacogenomics J. 2 2002 7 10
2. S. Partap, E.K. Curran, J.M. Propp, G.M. Le, K.L. Sainani, and P.G. Fisher Medulloblastoma incidence has not changed over time: a CBTRUS study J. Pediatr. Hematol. Oncol. 31 2009 970 971
3. M.P. Korah, N. Esiashvili, C.M. Mazewski, R.J. Hudgins, M. Tighiouart, A.J. Janss, F.P. Schwaibold, I.R. Crocker, W.J. Curran Jr., and R.B. Marcus Jr. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma Int. J. Radiat. Oncol. Biol. Phys. 77 2010 106 112
4. C. Dufour, A. Beaugrand, B. Pizer, J. Micheli, M.S. Aubelle, A. Fourcade, D. Couanet, A. Laplanche, C. Kalifa, and J. Grill Metastatic medulloblastoma in childhood: Chang's classification revisited Int. J. Surg. Oncol. 2012 2012 245385
5. Z. Culig Cytokine disbalance in common human cancers Biochim. Biophys. Acta 2011 1813 308 314
6. G. Sciume, A. Santoni, and G. Bernardini Chemokines and glioma: invasion and more J. Neuroimmunol. 224 2010 8 12
7. Y.S. Ng, R. Rohan, M.E. Sunday, D.E. Demello, and P.A. D'Amore Differential expression of VEGF isoforms in mouse during development and in the adult Dev. Dyn. 220 2001 112 121
8. P.K. Brastianos, and T.T. Batchelor VEGF inhibitors in brain tumors Clin. Adv. Hematol. Oncol. 7 2009 753 760 (768)
9. S. Shen, J. Fan, B. Cai, Y. Lv, M. Zeng, Y. Hao, F.G. Giancotti, and B.M. Fu Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo Exp. Physiol. 95 2010 369 379
10. M.C. Chamberlain Bevacizumab for the treatment of recurrent glioblastoma Clin. Med. Insights Oncol. 5 2011 117 129
11. T.J. Perren, A.M. Swart, J. Pfisterer, J.A. Ledermann, E. Pujade-Lauraine, G. Kristensen, M.S. Carey, P. Beale, A. Cervantes, C. Kurzeder, A. du Bois, J. Sehouli, R. Kimmig, A. Stahle, F. Collinson, S. Essapen, C. Gourley, A. Lortholary, F. Selle, M.R. Mirza, A. Leminen, M. Plante, D. Stark, W. Qian, M.K. Parmar, and A.M. Oza A phase 3 trial of bevacizumab in ovarian cancer N. Engl. J. Med. 365 2011 2484 2496
12. M.L. Slongo, B. Molena, A.M. Brunati, M. Frasson, M. Gardiman, M. Carli, G. Perilongo, A. Rosolen, and M. Onisto Functional VEGF and VEGF receptors are expressed in human medulloblastomas Neuro Oncol. 9 2007 384 392
13. G. Stockhammer, W. Poewe, S. Burgstaller, F. Deisenhammer, A. Muigg, S. Kiechl, E. Schmutzhard, H. Maier, S. Felber, P. Schumacher, E. Gunsilius, and G. Gastl Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis Neurology 54 2000 1670 1676
14. U. Herrlinger, H. Wiendl, M. Renninger, H. Forschler, J. Dichgans, and M. Weller Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value Br. J. Cancer 91 2004 219 224
15. B. van de Langerijt, J.M. Gijtenbeek, H.P. de Reus, F.C. Sweep, A. Geurts-Moespot, J.C. Hendriks, A.C. Kappelle, and M.M. Verbeek CSF levels of growth factors and plasminogen activators in leptomeningeal metastases Neurology 67 2006 114 119
16. P.F. Jacobsen, D.J. Jenkyn, and J.M. Papadimitriou Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice J. Neuropathol. Exp. Neurol. 44 1985 472 485
17. S. Puttmann, V. Senner, S. Braune, B. Hillmann, R. Exeler, C.H. Rickert, and W. Paulus Establishment of a benign meningioma cell line by hTERT-mediated immortalization Lab. Invest. 85 2005 1163 1171
18. M.A. Davare, T. Saneyoshi, and T.R. Soderling Calmodulin-kinases regulate basal and estrogen stimulated medulloblastoma migration via Rac1 J. Neurooncol. 104 2011 65 82
19. S. Ohshima-Hosoyama, T. Hosoyama, L.D. Nelon, and C. Keller IGF-1 receptor inhibition by picropodophyllin in medulloblastoma Biochem. Biophys. Res. Commun. 399 2010 727 732
20. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322
21. B. Chen, Y. Gao, T. Jiang, J. Ding, Y. Zeng, R. Xu, and X. Jiang Inhibition of tumor cell migration and invasion through knockdown of Rac1 expression in medulloblastoma cells Cell. Mol. Neurobiol. 31 2011 251 257
22. S. Zavarella, M. Nakada, S. Belverud, S.J. Coniglio, A. Chan, M.A. Mittler, S.J. Schneider, and M. Symons Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation J. Neurosurg. Pediatr. 4 2009 97 104
23. D.G. Aguilera, S. Goldman, and J. Fangusaro Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma Pediatr. Blood Cancer 56 2011 491 494
24. M. Snuderl, A. Batista, N.D. Kirkpatrick, C. Ruiz de Almodovar, L. Riedemann, E.C. Walsh, R. Anolik, Y. Huang, J.D. Martin, W. Kamoun, E. Knevels, T. Schmidt, C.T. Farrar, B.J. Vakoc, N. Mohan, E. Chung, S. Roberge, T. Peterson, C. Bais, B.H. Zhelyazkova, S. Yip, M. Hasselblatt, C. Rossig, E. Niemeyer, N. Ferrara, M. Klagsbrun, D.G. Duda, D. Fukumura, L. Xu, P. Carmeliet, and R.K. Jain Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma Cell 152 2013 1065 1076